Stanford Scientists Block 15-PGDH to Regrow Knee Cartilage, Targeting Osteoarthritis at Its Source
Updated
Updated · Bored Panda · Jun 10
Stanford Scientists Block 15-PGDH to Regrow Knee Cartilage, Targeting Osteoarthritis at Its Source
2 articles · Updated · Bored Panda · Jun 10
Summary
Stanford Medicine researchers found that blocking the aging-linked protein 15-PGDH can trigger knee cartilage regrowth by reprogramming existing cartilage cells rather than using stem cells.
The approach aims to treat osteoarthritis by repairing damaged tissue and restoring more youthful cell function, addressing joint degeneration itself instead of only easing pain.
Early experiments showed cartilage regeneration and improved joint function, while a related version of the drug has already cleared initial human safety testing for muscle weakness.
Researchers say the therapy could eventually be developed as an oral pill, potentially reducing the need for invasive procedures such as knee replacement surgery.
If later trials succeed, the strategy could open a broader regenerative-medicine path for age-related tissue repair and mobility loss.